VOYA Investment Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-521
| Closed | -$51K | – | 2887 |
|
|
2022
Q1 | $51K | Hold |
521
| – | – | ﹤0.01% | 2590 |
|
|
2021
Q4 | $85K | Sell |
521
-63
| -11% | -$13.8K | ﹤0.01% | 2686 |
|
|
2021
Q3 | $159K | Hold |
584
| – | – | ﹤0.01% | 2635 |
|
|
2021
Q2 | $231K | Sell |
584
-53
| -8% | -$24.7K | ﹤0.01% | 2526 |
|
|
2021
Q1 | $344K | Buy |
637
+21
| +3% | +$13.1K | ﹤0.01% | 2243 |
|
|
2020
Q4 | $233K | Buy |
616
+118
| +24% | +$46.9K | ﹤0.01% | 2345 |
|
|
2020
Q3 | $188K | Hold |
498
| – | – | ﹤0.01% | 2175 |
|
|
2020
Q2 | $245K | Sell |
498
-101
| -17% | -$45K | ﹤0.01% | 2061 |
|
|
2020
Q1 | $220K | Buy |
599
+82
| +16% | +$42.4K | ﹤0.01% | 2084 |
|
|
2019
Q4 | $366K | Buy |
517
+99
| +24% | +$68.1K | ﹤0.01% | 2068 |
|
|
2019
Q3 | $268K | Hold |
418
| – | – | ﹤0.01% | 2106 |
|
|
2019
Q2 | $366K | Buy |
418
+47
| +13% | +$32.3K | ﹤0.01% | 1975 |
|
|
2019
Q1 | $214K | Hold |
371
| – | – | ﹤0.01% | 2239 |
|
|
2018
Q4 | $104K | Hold |
371
| – | – | ﹤0.01% | 2394 |
|
|
2018
Q3 | $178K | Hold |
371
| – | – | ﹤0.01% | 2374 |
|
|
2018
Q2 | $168K | Sell |
371
-34
| -8% | -$21.6K | ﹤0.01% | 2411 |
|
|
2018
Q1 | $238K | Hold |
405
| – | – | ﹤0.01% | 2231 |
|
|
2017
Q4 | $252K | Hold |
405
| – | – | ﹤0.01% | 2230 |
|
|
2017
Q3 | $373K | Hold |
405
| – | – | ﹤0.01% | 2049 |
|
|
2017
Q2 | $378K | Buy |
405
+73
| +22% | +$71.6K | ﹤0.01% | 2010 |
|
|
2017
Q1 | $316K | Hold |
332
| – | – | ﹤0.01% | 2011 |
|
|
2016
Q4 | $267K | Hold |
332
| – | – | ﹤0.01% | 2135 |
|
|
2016
Q3 | $281 | Hold |
332
| – | – | ﹤0.01% | 2079 |
|
|
2016
Q2 | $274K | Hold |
332
| – | – | ﹤0.01% | 2079 |
|
|
2016
Q1 | $370K | Hold |
332
| – | – | ﹤0.01% | 1878 |
|
|
2015
Q4 | $414K | Hold |
332
| – | – | ﹤0.01% | 1842 |
|
|
2015
Q3 | $449K | Sell |
332
-45
| -12% | -$74.3K | ﹤0.01% | 1785 |
|
|
2015
Q2 | $678K | Buy |
377
+38
| +11% | +$59K | ﹤0.01% | 1707 |
|
|
2015
Q1 | $548K | Hold |
339
| – | – | ﹤0.01% | 1858 |
|
|
2014
Q4 | $258K | Hold |
339
| – | – | ﹤0.01% | 2356 |
|
|
2014
Q3 | $134K | Hold |
339
| – | – | ﹤0.01% | 2578 |
|
|
2014
Q2 | $205K | Hold |
339
| – | – | ﹤0.01% | 2550 |
|
|
2014
Q1 | $233K | Hold |
339
| – | – | ﹤0.01% | 2450 |
|
|
2013
Q4 | $221K | Buy |
+339
| New | +$202K | ﹤0.01% | 2462 |
|
Other funds holding TCRT
MP
DCM
LCM
VOYA Investment Management's TCRT Position: Q2 2022 in Review
VOYA Investment Management sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 521 shares — an estimated $51K sold.
VOYA Investment Management first reported a position in TCRT in Q4 2013 and held it in 34 quarters. The position peaked at $678K in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- VOYA Investment Management reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- VOYA Investment Management sold 521 Alaunos Therapeutics shares in Q2 2022, an estimated $51K.
- VOYA Investment Management first reported a position in Alaunos Therapeutics in Q4 2013 and held it in 34 quarters.
- VOYA Investment Management's Alaunos Therapeutics position peaked at $678K in Q2 2015.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.